Staphylococcal plasmids of the pT181 family replicate via a rolling circle mechanism, initiated by one of the nicking-closing Rep proteins [I]. These Rep proteins become covalently attached to the displaced DNA strand during replication, and following termination have been observed to retain a small oligonucleotide covalently linked to the protein. This Rep* adduct has been suggested to be incapable of further initiation of replication [2].
Staphylococcal plasmids of the pT181 family replicate via a rolling circle mechanism, initiated by one of the nicking-closing Rep proteins [I] . These Rep proteins become covalently attached to the displaced DNA strand during replication, and following termination have been observed to retain a small oligonucleotide covalently linked to the protein. This Rep* adduct has been suggested to be incapable of further initiation of replication [2] .
Using the RepD protein variant [3] and a synthetic oligonucleotide corresponding to the replication origin, we have generated this covalent adduct in vitro. Contrary to previous observations with RepC/C*, the RepD/D* adduct appears capable of a topoisomerase-like nicking-closing activity, indicative of potential replication initiator function in vivo.
The generation of RepD/D* in vitro is outlined in Figure 1 . A 24-base oligonucleotide, corresponding in sequence to the unique site of phosphodiester bond cleavage, is combined with RepD. Oligonucleotide cleavage is accompanied by covalent attachment of part of the substrate to one subunit of the protein dimer via the active site tyrosine (residue 191) and release of the 5' part of the substrate as a free oligonucleotide. The protein monomer covalently attached to DNA migrates anomalously on SDSpolyacrylamide gel electrophoresis (Figure 2 ). The reaction is reversible; addition of the 5' 13-base oligonucleotide to the RepD/D* heterodimer regenerates the RepD homodimer.
Purification of the RepD/D* heterodimer ( Figure 2 ) ensures none of the observed activities are attributable to unreacted RepD homodimer. These include the ability of RepD/D* to relax negatively supercoiled 6 2 2 1 , and its non-covalent binding to the replication origin as detected by a gel-shift assay.
RepD homodimer is capable of type I topoisomerase activity with plasmid substrates containing the cleavage site (represented by the 24-base oligonucleotide above) at the replication origin [3] . The rate of reaction is modulated by an adjacent specificity sequence within the origin: thus RepD will relax plasmids containing both elements by a factor of up to 300 times faster than those containing only the cleavage site, a factor considered crucial for the specific initiation of replication in vivo. 
lefi panel). Such a shifi is barely detectable with identical concentrations of the RepD/D* heterodimer (right panel).
The topoisomerase activity thus demonstrates the processes required for initiation of replication, namely the cleavage and religation of a specific phosphodiester bond at the origin of replication. Using this assay it is seen that the RepD/D* heterodimer retains some topoisomerase activity, but at a reduced rate of approximately 30-fold less than RepD homodimer (Figure 3 ). This rate is intermediate between the rates of relaxation of cognate and noncognate plasmids by RepD homodimer. Regeneration of RepD homodimer from RepD/D* by addition of the 13-base oligonucleotide results in full restoration of activity. The difference in relaxation rate of cognate and non-cognate plasmids by RepD reflects the difference in affinity for the specificity sequence described above. Preliminary gel shift analysis also shows that RepD/D* has reduced affinity for its cognate specificity sequence (Figure 4) , the calculated binding aftinity being at least an order of magnitude lower than that for RepD homodimer. The primary effect of the RepD* modification can therefore be attributed to reduced aftinity of the heterodimer for the replication origin, modulating the subsequent cleavage process that initiates replication in vivo or topoisomerisation in vitro.
In conclusion, RepD/D* has reduced but nonetheless detectable activity in vitro. In vivo the implications are for a modified protein that will have less aftinity for its replication origin. This may serve the control of replication in two ways, both to reduce subsequent initiation events by the same initiator protein and to dissociate the complex from the replication origin following completion of plasmid replication, making the origin accessible to newlysynthesised homodimer in further generations. However, as the reduction in activity is intermediate between that observed for specificity of the homodimer between cognate and non-cognate origins, an increase in intracellular protein concentration (such as found with certain copy mutants) may be sufficient to overcome the regulation of RepD/D*. 
